BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 27, 2000
View Archived Issues
Potent and selective octapeptide sst3 receptor antagonist identified by Swiss, U.S. researchers
Read More
Myogen and BASF to codevelop BSF-208075
Read More
Zonagen and Wyeth-Ayerst sign human contraceptive vaccine agreement
Read More
Oxford GlycoSciences and Pfizer enter biomarker discovery alliance
Read More
AstraZeneca continues to make progress across development portfolio
Read More
SLIL designs conformationally restricted polyamine analogues for cancer therapy
Read More
AstraZeneca seeks FDA approval for pediatric indication of Naropin
Read More
EU recommends approval of PegIntron/Rebetol combination for hepatitis C treatment
Read More
CeNeS grants license to Shire for dopamine D1 agonist program
Read More
Japanese launch of maxacalcitol announced
Read More
Inflazyme's novel asthma therapy enters phase II following U.K. approval
Read More
R.W. Johnson delays North American phase III trial of influenza inhibitor
Read More
Starlix approved by FDA for treatment of type 2 diabetes
Read More
Actis for erectile dysfunction approved by FDA for OTC marketing
Read More
Once-daily Detrol approved by FDA for treatment of overactive bladder
Read More
Novel method for treating autoimmune diseases revealed by UAB Research Foundation
Read More
Sumitomo discloses thiourea derivatives with ECE-inhibitory activity
Read More
Sumitomo reports quinazoline derivatives with potential for allergic disease treatment
Read More
Novel steroid compounds demonstrate anticancer potential
Read More
Tanabe Seiyaku claims isoquinoline derivatives with cardiovascular activity
Read More